Document is current
Any future updates will be listed below
-
Authors
Wang, Chih-Yuan https://orcid.org/0000-0002-6742-3935
Zhou, Fang L.
Gandhi, Aakash B.
Lee, Tsung-Ying https://orcid.org/0000-0003-0633-3140
Cui, Nancy
Mao, Jiuo-Shan https://orcid.org/0009-0002-2960-1195
Chen, Jung-Fu
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 8 December 2023
Accepted: 18 March 2024
First Online: 20 April 2024
Declarations
:
: Chih-Yuan Wang: Nothing to disclose. Fang Liz Zhou, Aakash Gandhi, Nancy Cui and Jiuo-Shan Mao: Employees of Sanofi; may hold shares and/or stock options in the company. Tsung-Ying Lee: Intern of Sanofi at time of study. Jung-Fu Chen: Nothing to disclose.
: This study was conducted in accordance with the guidelines for Good Epidemiology Practice and the Declaration of Helsinki. The study was approved by the local Institutional Review Board review of the National Taiwan University Hospital (202211018RSC) and Kaohsiung Chang Gung Hospital (202201756B0A3). The study used de-identified data from H2S retrospectively and patients were not recruited specifically for this study. All patients who registered to use the H2S app provided consent for their data to be analyzed for research purposes. Permission was obtained from the owners of H2S to conduct this research using data from the platform.
